Clinical Trial Update: Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial investigating the role of gastrointestinal-mediated glucose disposal and incretin defects in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes | NA | Status: COMPLETED